Preparation of pro-oncogenic mutant forms V659E and V659Q of the transmembrane domain of receptor protein kinase ErbB2 for structural studies

Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology

Volumn 7, Issue 2, 2013, Pages 91-99

  Bocharova, O V ^a   Bocharov, E V ^a   Mineev, K S ^a   Dubinnyi, M A ^a   Mishin, A V ^a   Arseniev, A S ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

NMR spectroscopy; receptor tyrosine kinases; recombinant protein; transmembrane domain

Indexed keywords

CARBON 13; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUTAMIC ACID; GLUTAMINE; HYBRID PROTEIN; NITROGEN 15; RECOMBINANT ENZYME; THIOREDOXIN; THROMBIN; VALINE;

AFFINITY CHROMATOGRAPHY; AMINO ACID SUBSTITUTION; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME PURIFICATION; ENZYME STRUCTURE; ESCHERICHIA COLI; GENE SEQUENCE; ION EXCHANGE CHROMATOGRAPHY; MUTANT; MUTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMID; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84879393678     PISSN: 19907478     EISSN: 19907494     Source Type: Journal    
DOI: 10.1134/S1990747813010029     Document Type: Article

References (27)

1. Yarden Y., Sliwkowski M.X. 2001. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127-137.
2. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell. 103, 211-225.
3. Vajo Z., Francomano C.A., Wilkin D.J. 2000. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr. Rev. 21, 23-39.
4. Passos-Bueno M.R., Wilcox W.R., Jabs E.W., Sertie A.L., Alonso L.G., Kitoh H. 1999. Clinical spectrum of fibroblast growth factor receptor mutations. Hum. Mutat. 14, 115-125.
5. Cappellen D., de Oliveira C., Ricol D., de Medina S.G., Bourdin J., Sastre-Garau X., Chopin D., Thiery J.P., Radvanyi F. 1999. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat. Genet. 23, 18-20.
6. Schlessinger J. 2002. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell. 110, 669-672.
7. Tao R.H., Maruyama I.N. 2008. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J. Cell. Sci. 121, 3207-3217.
8. Holbro T., Civenni G., Hynes N.E. 2003. The ErbB receptors and their role in cancer progression. Exp. Cell Res. 284, 99-110.
9. Woodburn J.R. 1999. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol. Ther. 82, 241-250.
10. Olayioye M.A., Neve R.M., Lane H.A., Hynes N.E. 2000. The ErbB signaling network: Receptor heterodimerization in development and cancer. EMBO J. 19, 3159-3167.
11. Bargmann C.I., Hung M.-C., Weinberg R.A. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell. 45, 649-657.
12. Xie D., Shu X.O., Deng Z., Wen W.Q., Creek K.E., Dai Q., Gao Y.T., Jin F., Zheng W. 2000. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J. Nat. Cancer Inst. 92, 412-417.
13. Bennasroune A., Fickova M., Gardin A., Dirrig-Grosch S., Aunis D., Crémel G., Hubert P. 2004. Transmembrane peptides as inhibitors of ErbB receptor signaling. Mol. Biol. Cell. 15, 3464-3474.
14. Duneau J.P., Vegh A.P., Sturgis J.N. A dimerization hierarchy in the transmembrane domains of the HER receptor family. 2007. Biochemistry. 46, 2010-2019.
15. Li E., Hristova K. 2006. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry. 45, 6241-6251.
16. Mendrola J.M., Berger M.B., King M.C., Lemmon M.A. 2002. The single transmembrane domains of ErbB receptors self-associate in cell membranes. J. Biol. Chem. 277, 4704-4712.
17. Enosh A., Fleishman S.J., Ben-Tal N., Halperin D. 2007. Prediction and simulation of motion in pairs of transmembrane alpha-helices. Bioinformatics. 23, 212-218.
18. Smith S.O., Smith C., Shekar S., Peersen O., Ziliox M., Aimoto S. 2002. Transmembrane interactions in the activation of the Neu receptor tyrosine kinase. Biochemistry. 41, 9321-9332.
19. Fleishman S.J., Schlessinger J., Ben-Tal N. 2002. A putative molecular-activation switch in the transmembrane domain of ErbB2. Proc. Natl. Acad. Sci. USA. 99, 15937-15940.
20. Bocharov E.V., Mineev K.S., Volynsky P.E., Ermolyuk Ya.S., Tkach E.N., Sobol A.G., Chupin V.V., Kirpichnikov M.P., Efremov R.G., Arseniev A.S. 2008. Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state. J. Biol. Chem. 283, 6950-6956.
21. Goncharuk S.A., Goncharuk M.V., Mayzel M.L., Lesovoy D.M., Chupin V.V., Bocharov E.V., Arseniev A.S., Kirpichnikov M.P. 2011. Bacterial synthesis and purification of normal and mutant forms of human FGFR3 transmembrane segment. Acta Naturae. 3, 77-84.
22. Laemmli U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227, 680-685.
23. Mineev K.S., Bocharov E.V., Pustovalova Y.E., Bocharova O.V., Chupin V.V., Arseniev A.S. 2010. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases. J. Mol. Biol. 400, 231-243.
24. Bocharov E.V., Mayzel M.L., Volynsky P.E., Mineev K.S., Tkach E.N., Ermolyuk Ya.S., Schulga A.A., Efremov R.G., Arseniev A.S. 2010. Left-handed dimer of EphA2 transmembrane domain: Helix packing diversity among receptor tyrosine kinases. Biophys. J. 98, 881-889.
25. Bocharov E.V., Mayzel M.L., Volynsky P.E., Goncharuk M.V., Ermolyuk Ya.S., Schulga A.A., Artemenko E.O., Efremov R.G., Arseniev A.S. 2008. Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1. J. Biol. Chem. 283, 29385-29395.
26. Goncharuk M.V., Shulga A.A., Ermolyuk Ya.S., Tkach E.N., Goncharuk S.A., Pustovalova Yu.E., Mineev K.S., Bocharov E.V., Maslennikov I.V., Arseniev A.S. 2011. Bacterial synthesis, purification, and solubilization of transmembrane segments of ErbB family members. Mol. Biol. (Rus). 45, 892-902.
27. Bocharov E.V., Pustovalova Y.E., Pavlov K.V., Volynsky P.E., Goncharuk M.V., Ermolyuk Y.S., Karpunin D.V., Schulga A.A., Kirpichnikov M.P., Efremov R.G., Maslennikov I.V., Arseniev A.S. 2007. Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger. J. Biol. Chem. 282, 16256-16266.